JP2024527939A - 脂質ナノ粒子組成物を調製するためのプロセス - Google Patents

脂質ナノ粒子組成物を調製するためのプロセス Download PDF

Info

Publication number
JP2024527939A
JP2024527939A JP2024504833A JP2024504833A JP2024527939A JP 2024527939 A JP2024527939 A JP 2024527939A JP 2024504833 A JP2024504833 A JP 2024504833A JP 2024504833 A JP2024504833 A JP 2024504833A JP 2024527939 A JP2024527939 A JP 2024527939A
Authority
JP
Japan
Prior art keywords
lipid
composition
lipid nanoparticle
nanoparticle composition
buffer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024504833A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024527939A5 (enExample
Inventor
エイチ スミス，マイケル
スード，ニミル
ティアン，チャン
ダブリュー ドハーティ，ダニエル
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ModernaTx Inc
Original Assignee
ModernaTx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ModernaTx Inc filed Critical ModernaTx Inc
Publication of JP2024527939A publication Critical patent/JP2024527939A/ja
Publication of JP2024527939A5 publication Critical patent/JP2024527939A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2024504833A 2021-07-26 2022-07-25 脂質ナノ粒子組成物を調製するためのプロセス Pending JP2024527939A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163225815P 2021-07-26 2021-07-26
US63/225,815 2021-07-26
PCT/US2022/038151 WO2023009421A1 (en) 2021-07-26 2022-07-25 Processes for preparing lipid nanoparticle compositions

Publications (2)

Publication Number Publication Date
JP2024527939A true JP2024527939A (ja) 2024-07-26
JP2024527939A5 JP2024527939A5 (enExample) 2025-08-04

Family

ID=82899410

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024504833A Pending JP2024527939A (ja) 2021-07-26 2022-07-25 脂質ナノ粒子組成物を調製するためのプロセス

Country Status (6)

Country Link
US (1) US20240335393A1 (enExample)
EP (1) EP4376814A1 (enExample)
JP (1) JP2024527939A (enExample)
CN (1) CN118019527A (enExample)
TW (1) TW202320736A (enExample)
WO (1) WO2023009421A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3675817A1 (en) 2017-08-31 2020-07-08 Modernatx, Inc. Methods of making lipid nanoparticles
CZ310613B6 (cs) 2020-09-23 2026-01-28 Ústav organické chemie a biochemie AV ČR, v. v. i. Lipidoidy pro transfekci nukleových kyselin a jejich použití
CZ310443B6 (cs) 2021-07-19 2025-06-25 Ústav organické chemie a biochemie AV ČR, v. v. i. Cyklohexanové lipidoidy pro transfekci nukleových kyselin a jejich použití
TW202539706A (zh) * 2023-11-14 2025-10-16 大陸商上海瑞宏迪醫藥有限公司 一種脂質奈米粒的製備方法和應用
CN121099987A (zh) * 2024-04-08 2025-12-09 苏州艾博生物科技有限公司 脂质纳米颗粒制剂及其制备方法
GB202414932D0 (en) 2024-10-10 2024-11-27 Apoha Ltd Method and apparatus

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5681702A (en) 1994-08-30 1997-10-28 Chiron Corporation Reduction of nonspecific hybridization by using novel base-pairing schemes
WO2006044660A2 (en) * 2004-10-14 2006-04-27 Vanderbilt University Functionalized solid lipid nanoparticles and methods of making and using same
CN107028886A (zh) * 2009-11-04 2017-08-11 不列颠哥伦比亚大学 含有核酸的脂质粒子及相关的方法
EP2625189B1 (en) 2010-10-01 2018-06-27 ModernaTX, Inc. Engineered nucleic acids and methods of use thereof
CA2824526C (en) 2011-01-11 2020-07-07 Alnylam Pharmaceuticals, Inc. Pegylated lipids and their use for drug delivery
WO2013103659A1 (en) 2012-01-04 2013-07-11 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Stabilizing rna by incorporating chain-terminating nucleosides at the 3'-terminus
WO2014093924A1 (en) 2012-12-13 2014-06-19 Moderna Therapeutics, Inc. Modified nucleic acid molecules and uses thereof
PL2922554T3 (pl) 2012-11-26 2022-06-20 Modernatx, Inc. Na zmodyfikowany na końcach
US20160022840A1 (en) 2013-03-09 2016-01-28 Moderna Therapeutics, Inc. Heterologous untranslated regions for mrna
EP2968391A1 (en) 2013-03-13 2016-01-20 Moderna Therapeutics, Inc. Long-lived polynucleotide molecules
CN105143456A (zh) 2013-03-15 2015-12-09 不列颠哥伦比亚大学 用于转染的脂质纳米粒子和相关方法
US11564893B2 (en) * 2015-08-17 2023-01-31 Modernatx, Inc. Methods for preparing particles and related compositions
JP6948313B6 (ja) * 2015-09-17 2022-01-14 モデルナティエックス インコーポレイテッド 治療剤の細胞内送達のための化合物および組成物
PL3386484T3 (pl) 2015-12-10 2022-07-25 Modernatx, Inc. Kompozycje i sposoby dostarczania środków terapeutycznych
JP7488193B2 (ja) * 2018-05-24 2024-05-21 トランスレイト バイオ， インコーポレイテッド チオエステルカチオン性脂質
HRP20240586T1 (hr) * 2018-10-09 2024-07-19 The University Of British Columbia Sastavi i sustavi koji sadrže transfekcijske sposobne vezikle bez organskih otapala i deterdženta i s njim povezanim postupcima
AU2020350759A1 (en) * 2019-09-19 2022-03-31 Modernatx, Inc. Branched tail lipid compounds and compositions for intracellular delivery of therapeutic agents

Also Published As

Publication number Publication date
US20240335393A1 (en) 2024-10-10
TW202320736A (zh) 2023-06-01
WO2023009421A1 (en) 2023-02-02
EP4376814A1 (en) 2024-06-05
CN118019527A (zh) 2024-05-10

Similar Documents

Publication Publication Date Title
US20240366522A1 (en) Processes for preparing lipid nanoparticle compositions for the delivery of payload molecules to airway epithelium
JP2024527939A (ja) 脂質ナノ粒子組成物を調製するためのプロセス
US12144895B2 (en) Stabilized formulations of lipid nanoparticles
US20230285310A1 (en) Compositions for the delivery of payload molecules to airway epithelium
EP3852728B1 (en) Preparation of lipid nanoparticles and methods of administration thereof
US20230285297A1 (en) Methods of preparing lipid nanoparticles
CN113939282A (zh) 制备脂质纳米颗粒的方法
US20250049727A1 (en) Compositions for the delivery of payload molecules to airway epithelium
US20250214046A1 (en) Cross mixers for lipid nanoparticle production, and methods of operating the same
US20250313830A1 (en) Messenger ribonucleic acids with extended half-life
US20250049728A1 (en) Processes for preparing lipid nanoparticles
WO2024091918A2 (en) Methods of lipid nanoparticle production in cross-mixers
US20260014281A1 (en) Peg targeting compounds for delivery of therapeutics
WO2024197310A1 (en) Peg targeting compounds for delivery of therapeutics
EP4683666A1 (en) Peg targeting compounds for delivery of therapeutics

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250725

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250725